Hiroo Amano Selected Research

Hiroo Amano Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2011
4	Neoplasms (Cancer) 01/2020 - 10/2011
3	Hypersensitivity (Allergy) 01/2021 - 05/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2022 - 12/2020
2	Atopic Dermatitis (Atopic Eczema) 08/2021 - 02/2008
2	Dermatomyositis (Dermatopolymyositis) 08/2017 - 08/2016
2	Necrosis 01/2014 - 01/2008
1	Dermatitis 10/2022
1	Carcinogenesis 01/2022
1	Unconsciousness (Loss of Consciousness) 09/2021
1	Arthralgia (Joint Pain) 08/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020
1	Psoriatic Arthritis 10/2020
1	Merkel Cell Carcinoma 08/2020
1	Edema (Dropsy) 01/2020
1	Pilomatrixoma 01/2020
1	Erythema 11/2019
1	Anaphylaxis (Anaphylactic Shock) 07/2019
1	Seasonal Allergic Rhinitis (Hay Fever) 07/2019
1	Extramammary Paget Disease (Paget Disease, Extramammary) 03/2019
1	Keratitis, Ichthyosis, and Deafness (KID) Syndrome 11/2018
1	Infections 11/2018
1	Netherton Syndrome 11/2018
1	Kaposi Sarcoma (Kaposi's Sarcoma) 07/2018
1	Piebaldism (Partial Albinism) 07/2018
1	Darier Disease (Darier's Disease) 04/2018
1	Pyogenic Granuloma 11/2017
1	Amyloidosis 08/2017
1	Telangiectasis (Telangiectasia) 05/2017
1	Hypoxia (Hypoxemia) 11/2015
1	Amyopathic dermatomyositis 10/2015
1	Bowen's Disease (Disease, Bowen) 09/2015
1	Crohn Disease (Crohn's Disease) 08/2015
1	Skin Diseases (Skin Disease) 08/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2015
1	Prurigo 03/2014
1	Eosinophilia 05/2010
1	Panniculitis 05/2010
1	Vitiligo 03/2008
1	Ulcerative Colitis 01/2008
1	Systemic Scleroderma (Systemic Sclerosis) 01/2008

Drug/Important Bio-Agent (IBA)

2	risankizumabIBA 07/2022 - 10/2020
2	Docetaxel (Taxotere)FDA Link 12/2020 - 03/2019
2	Proteins (Proteins, Gene)FDA Link 07/2018 - 01/2018
1	Doxycycline (Periostat)FDA LinkGeneric 10/2022
1	COVID-19 VaccinesIBA 07/2022
1	Messenger RNA (mRNA)IBA 07/2022
1	binimetinibIBA 01/2022
1	encorafenibIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Dual-Specificity PhosphatasesIBA 01/2022
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2021
1	dupilumabIBA 08/2021
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2021
1	Atropine FDA LinkGeneric 01/2021
1	Adalimumab (Humira)FDA Link 10/2020
1	B7-H1 AntigenIBA 08/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	CollagenIBA 01/2020
1	AcrylatesIBA 11/2019
1	TeaIBA 07/2019
1	Keratin-19 (Keratin 19)IBA 03/2019
1	AllergensIBA 11/2018
1	Benzoyl Peroxide FDA LinkGeneric 04/2018
1	Antineoplastic Agents (Antineoplastics)IBA 02/2018
1	quinone (benzoquinone)IBA 02/2018
1	beta-lapachoneIBA 02/2018
1	salvinIBA 02/2018
1	tanespimycin (17AAG)IBA 02/2018
1	NAD (NADH)IBA 02/2018
1	Oxidoreductases (Dehydrogenase)IBA 02/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	Capecitabine (Xeloda)FDA Link 11/2017
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 08/2017
1	Collagen Type IV (Type IV Collagen)IBA 05/2017
1	Periodic AcidIBA 05/2017
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 08/2016
1	AntibodiesIBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	Small Interfering RNA (siRNA)IBA 11/2015
1	Dapsone FDA Link 10/2015
1	Imiquimod (Aldara)FDA LinkGeneric 09/2015
1	Methotrexate (Mexate)FDA LinkGeneric 07/2015
1	Raltegravir Potassium FDA Link 03/2014
1	Hydroxyzine (Vistaril)FDA LinkGeneric 01/2014
1	Contrast MediaIBA 10/2011
1	ApoferritinsIBA 10/2011
1	calcium heparin (Calciparine)FDA Link 05/2010
1	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 03/2008
1	Ointments (Pastes)IBA 03/2008
1	Corticotropin-Releasing HormoneIBA 02/2008

Therapy/Procedure

6	Therapeutics 12/2020 - 01/2008
2	Radiotherapy 08/2020 - 07/2018
2	Drug Therapy (Chemotherapy) 03/2019 - 02/2018
1	Blood Component Removal (Apheresis) 08/2015
1	Tattooing 01/2011